RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. RayThera

RayThera

RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.

Latest funding

$110M Series A ·

Led by Foresite Capital · Source: fundraisingfox.com

Funding history ↓

Acquired by BBiogen on for $1B · PMLiVE.

Website: raythera.com.
LinkedIn: biogen-.
Category: Health and bio.
Sectors: Biotechnology, Medical.
Stage: Series A.
Based in: San Diego, United States.
Last round: Apr 4, 2025 · 591 days ago.
Headcount: 1–10 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredOct 5, 2019 (7 years old)

Funding rounds

DateRoundAmountLeadSource
Series A$110MFForesite Capitalfundraisingfox.com

Timeline

  1. Acquired by BBiogen · $1B
    Source: PMLiVE
  2. Website created

Founders and team

Investors

Companies like RayThera

Other companies backed by Foresite Capital

Foresite Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/raythera (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy